SEC Comment Letter for CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487) (CLGN) — Feb 15, 2019
CollPlant Biotechnologies Ltd (CLGN) (CIK 0001631487)
Date: Feb. 15, 2019 · CIK: 0001631487 · Accession: 0000000000-19-002491
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229486
Letter
February 15, 2019 Eran Rotem Chief Financial Officer CollPlant Holdings Ltd. 3 Sapir Street, Weizmann Science Park Ness-Ziona 74140, Israel Re:CollPlant Holdings Ltd. Registration Statement on Form F-3 Filed February 1, 2019 File No. 333-229486 Dear Mr. Rotem: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Eric Atallah at (202) 551-3663 with any questions. Sincerely, Division of Corporation Finance Office of Electronics and Machinery cc: Gary Emmanuel
Show Raw Text
February 15, 2019
Eran Rotem
Chief Financial Officer
CollPlant Holdings Ltd.
3 Sapir Street, Weizmann Science Park
Ness-Ziona 74140, Israel
Re:CollPlant Holdings Ltd.
Registration Statement on Form F-3
Filed February 1, 2019
File No. 333-229486
Dear Mr. Rotem:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Eric Atallah at (202) 551-3663 with any questions.
Sincerely,
Division of Corporation Finance
Office of Electronics and Machinery
cc: Gary Emmanuel